Arrowstreet Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $404M | Buy |
4,659,425
+423,178
| +10% | +$40.5M | 0.22% | 94 |
|
|
2025
Q4 | $407M | Buy |
4,236,247
+1,805,524
| +74% | +$175M | 0.24% | 95 |
|
|
2025
Q3 | $232M | Buy |
2,430,723
+935,941
| +63% | +$86M | 0.15% | 138 |
|
|
2025
Q2 | $130M | Buy |
1,494,782
+1,148,803
| +332% | +$97.4M | 0.09% | 212 |
|
|
2025
Q1 | $31.1M | Sell |
345,979
-836,738
| -71% | -$74.9M | 0.03% | 467 |
|
|
2024
Q4 | $94.5M | Sell |
1,182,717
-2,341,448
| -66% | -$203M | 0.08% | 232 |
|
|
2024
Q3 | $317M | Sell |
3,524,165
-1,221,362
| -26% | -$103M | 0.27% | 78 |
|
|
2024
Q2 | $374M | Sell |
4,745,527
-97,136
| -2% | -$7.96M | 0.33% | 69 |
|
|
2024
Q1 | $422M | Buy |
4,842,663
+365,166
| +8% | +$31.2M | 0.39% | 56 |
|
|
2023
Q4 | $369M | Buy |
4,477,497
+870,000
| +24% | +$66.3M | 0.39% | 58 |
|
|
2023
Q3 | $283M | Sell |
3,607,497
-2,143,373
| -37% | -$179M | 0.34% | 66 |
|
|
2023
Q2 | $507M | Sell |
5,750,870
-1,492,493
| -21% | -$128M | 0.62% | 31 |
|
|
2023
Q1 | $584M | Sell |
7,243,363
-1,520,918
| -17% | -$124M | 0.76% | 26 |
|
|
2022
Q4 | $681M | Buy |
8,764,281
+1,602,609
| +22% | +$130M | 0.95% | 19 |
|
|
2022
Q3 | $578M | Buy |
7,161,672
+3,391,293
| +90% | +$305M | 0.85% | 20 |
|
|
2022
Q2 | $338M | Buy |
3,770,379
+2,467,045
| +189% | +$250M | 0.48% | 55 |
|
|
2022
Q1 | $145M | Sell |
1,303,334
-554,603
| -30% | -$58.6M | 0.18% | 139 |
|
|
2021
Q4 | $192M | Buy |
1,857,937
+1,273,860
| +218% | +$148M | 0.24% | 107 |
|
|
2021
Q3 | $73.2M | Sell |
584,077
-118,906
| -17% | -$15.4M | 0.09% | 235 |
|
|
2021
Q2 | $87.3M | Buy |
+702,983
| New | +$88.3M | 0.11% | 204 |
|
|
2021
Q1 | – | Sell |
-20,500
| Closed | -$2.4M | – | 2410 |
|
|
2020
Q4 | $2.4M | Buy |
+20,500
| New | +$2.26M | ﹤0.01% | 1535 |
|
|
2020
Q3 | – | Sell |
-1,662,858
| Closed | -$152M | – | 2442 |
|
|
2020
Q2 | $152M | Buy |
1,662,858
+287,749
| +21% | +$27.6M | 0.28% | 63 |
|
|
2020
Q1 | $124M | Buy |
+1,375,109
| New | +$146M | 0.35% | 48 |
|
|
2019
Q3 | – | Sell |
-33,280
| Closed | -$3.24M | – | 1652 |
|
|
2019
Q2 | $3.24M | Buy |
+33,280
| New | +$3.04M | 0.01% | 775 |
|
|
2019
Q1 | – | Sell |
-284,166
| Closed | -$25.8M | – | 1834 |
|
|
2018
Q4 | $25.8M | Buy |
284,166
+273,966
| +2,686% | +$25.6M | 0.07% | 269 |
|
|
2018
Q3 | $1M | Buy |
+10,200
| New | +$943K | ﹤0.01% | 799 |
|
|
2018
Q1 | – | Sell |
-2,693,463
| Closed | -$217M | – | 1248 |
|
|
2017
Q4 | $217M | Sell |
2,693,463
-1,255,583
| -32% | -$101M | 0.52% | 45 |
|
|
2017
Q3 | $307M | Buy |
3,949,046
+225,563
| +6% | +$18.7M | 0.82% | 29 |
|
|
2017
Q2 | $330M | Buy |
3,723,483
+278,491
| +8% | +$23.5M | 1% | 20 |
|
|
2017
Q1 | $278M | Buy |
+3,444,992
| New | +$269M | 1.02% | 16 |
|
|
2016
Q4 | – | Sell |
-2,542,682
| Closed | -$220M | – | 2184 |
|
|
2016
Q3 | $220M | Buy |
2,542,682
+984,707
| +63% | +$85.8M | 0.72% | 26 |
|
|
2016
Q2 | $135M | Buy |
1,557,975
+1,548,975
| +17,211% | +$125M | 0.45% | 54 |
|
|
2016
Q1 | $675K | Sell |
9,000
-293,100
| -97% | -$22.1M | ﹤0.01% | 1065 |
|
|
2015
Q4 | $23.2M | Buy |
302,100
+275,700
| +1,044% | +$20.8M | 0.11% | 187 |
|
|
2015
Q3 | $1.77M | Buy |
+26,400
| New | +$1.94M | 0.01% | 778 |
|
|
2013
Q3 | – | Sell |
-89,103
| Closed | -$4.59M | – | 1084 |
|
|
2013
Q2 | $4.59M | Buy |
+89,103
| New | +$4.4M | 0.03% | 338 |
|
Other funds holding MDT
VCM
VPM
Arrowstreet Capital's MDT Position: Q1 2026 in Review
Arrowstreet Capital increased its Medtronic (MDT) stake by 10% in Q1 2026, buying an estimated $40.5M and bringing the position to 4,659,425 shares worth $404M. The position accounts for 0.22% of the portfolio, ranked #94.
Arrowstreet Capital first reported a position in MDT in Q2 2013 and has held it in 36 quarters since. The position peaked at $681M in Q4 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Arrowstreet Capital held 4,659,425 shares of Medtronic worth $404M as of Q1 2026.
- Arrowstreet Capital bought 423,178 Medtronic shares in Q1 2026, an estimated $40.5M.
- Medtronic made up 0.22% of Arrowstreet Capital's portfolio in Q1 2026, its #94 holding.
- Arrowstreet Capital first reported a position in Medtronic in Q2 2013 and has held it in 36 quarters since.
- Arrowstreet Capital's Medtronic position peaked at $681M in Q4 2022.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.